AVITA Medical's Full Year 2025 Total Revenues Rise Around 11% Year-Over-Year, Shares Jump 7%

MT Newswires Live01-14

AVITA Medical (ASX:AVH) said that its total revenue for the full year 2025 came in at around AU$71.6 million, rising around 11% compared to AU$64.3 million for full year 2024, according to a Wednesday Australian bourse filing.

The firm also reported total net revenue of around AU$17.6 million in the fourth quarter of 2025, compared to AU$18.4 million in the fourth quarter of 2024.

Its full-year 2026 revenue is expected to be in the range of around AU$80 million to AU$85 million.

The firm also closed a five-year credit facility from Perceptive Advisors. An initial AU$50 million was funded with the option to draw an additional AU$10 million through the end of the first quarter 2027. The proceeds will be used to repay AVITA's outstanding debt as well as to support the further growth of its acute wound care portfolio.

Its shares rose 7% in recent trading on Wednesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603180654?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 09:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603180654","market":"fut","top_or_hot":-1,"title":"AVITA Medical's Full Year 2025 Total Revenues Rise Around 11% Year-Over-Year, Shares Jump 7%","media":"MT Newswires Live","content":"<html><body><p> AVITA Medical (ASX:AVH) said that its total revenue for the full year 2025 came in at around AU$71.6 million, rising around 11% compared to AU$64.3 million for full year 2024, according to a Wednesday Australian bourse filing.</p><p>The firm also reported total net revenue of around AU$17.6 million in the fourth quarter of 2025, compared to AU$18.4 million in the fourth quarter of 2024.</p><p>Its full-year 2026 revenue is expected to be in the range of around AU$80 million to AU$85 million.</p><p>The firm also closed a five-year credit facility from Perceptive Advisors. An initial AU$50 million was funded with the option to draw an additional AU$10 million through the end of the first quarter 2027. The proceeds will be used to repay AVITA's outstanding debt as well as to support the further growth of its acute wound care portfolio.</p><p>Its shares rose 7% in recent trading on Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AVITA Medical's Full Year 2025 Total Revenues Rise Around 11% Year-Over-Year, Shares Jump 7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAVITA Medical's Full Year 2025 Total Revenues Rise Around 11% Year-Over-Year, Shares Jump 7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-14 09:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> AVITA Medical (ASX:AVH) said that its total revenue for the full year 2025 came in at around AU$71.6 million, rising around 11% compared to AU$64.3 million for full year 2024, according to a Wednesday Australian bourse filing.</p><p>The firm also reported total net revenue of around AU$17.6 million in the fourth quarter of 2025, compared to AU$18.4 million in the fourth quarter of 2024.</p><p>Its full-year 2026 revenue is expected to be in the range of around AU$80 million to AU$85 million.</p><p>The firm also closed a five-year credit facility from Perceptive Advisors. An initial AU$50 million was funded with the option to draw an additional AU$10 million through the end of the first quarter 2027. The proceeds will be used to repay AVITA's outstanding debt as well as to support the further growth of its acute wound care portfolio.</p><p>Its shares rose 7% in recent trading on Wednesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TSS","symbol_name":"Total System Services","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2603180654","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603180654","pubTimestamp":1768352831,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"AVITA Medical  said that its total revenue for the full year 2025 came in at around AU$71.6 million, rising around 11% compared to AU$64.3 million for full year 2024, according to a Wednesday Australian bourse filing.The firm also reported total net revenue of around AU$17.6 million in the fourth quarter of 2025, compared to AU$18.4 million in the fourth quarter of 2024.Its full-year 2026 revenue is expected to be in the range of around AU$80 million to AU$85 million.The firm also closed a five-year credit facility from Perceptive Advisors. An initial AU$50 million was funded with the option to draw an additional AU$10 million through the end of the first quarter 2027. The proceeds will be used to repay AVITA's outstanding debt as well as to support the further growth of its acute wound care portfolio.Its shares rose 7% in recent trading on Wednesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TSS":"Total System Services"},"translate_title":"阿维塔医疗2025年全年总收入同比增长约11%，股价上涨7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TSS":1.5},"content_text":"AVITA Medical (ASX:AVH) said that its total revenue for the full year 2025 came in at around AU$71.6 million, rising around 11% compared to AU$64.3 million for full year 2024, according to a Wednesday Australian bourse filing.The firm also reported total net revenue of around AU$17.6 million in the fourth quarter of 2025, compared to AU$18.4 million in the fourth quarter of 2024.Its full-year 2026 revenue is expected to be in the range of around AU$80 million to AU$85 million.The firm also closed a five-year credit facility from Perceptive Advisors. An initial AU$50 million was funded with the option to draw an additional AU$10 million through the end of the first quarter 2027. The proceeds will be used to repay AVITA's outstanding debt as well as to support the further growth of its acute wound care portfolio.Its shares rose 7% in recent trading on Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603180654","isCrawlerRequest":true}